When companies apply to get their biocidal active substances approved or have their biocidal products authorised across the whole EU, individual EU member states check and evaluate the applications. Then, it is the Biocidal Products Committee that forms an opinion on the evaluation. These opinions are sent to the European Commission which takes the final decision on whether or not to approve the substance for biocidal use. Listen to Erik van de Plassche, Chair of the Biocidal Products Committee sharing the highlights from the December meeting. The Committee discussed several active substance applications and two Union authorisations. Our focus in this episode is on the requests that the Committee received from the Commission related to endocrine-disrupting properties of two active substances. Give us feedbackMore**************Subscribe to our YouTube channel Subscribe to our Safer Chemicals Podcast Subscribe to our news Follow us on: *Twitter *Facebook *LinkedIn Visit our website Disclaimer: Views expressed by interviewees do not necessarily represent the official position of the European Chemicals Agency. All content is up to date at the time of publication.Hosted by Ausha. See ausha.co/privacy-policy for more information.